GlassScriptPhysician profile
Gabor Zoltay
NPI 1063576205
$9,503.16
in general payments reported to CMS, 2019-2025
45 companies · $1,177 in 2025
The $1,177 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,899 · 2020: $264 · 2021: $1,205 · 2022: $1,566 · 2023: $1,319 · 2024: $1,074 · 2025: $1,177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,469 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,468.71 |
| Education | $100.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,687.18 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Emd Serono, INC. | $633.26 | 2019-2025 | Mavenclad |
| Ucb, INC. | $603.21 | 2019-2025 | Nayzilam, Briviact |
| Genzyme Corporation | $588.76 | 2019-2024 | |
| Sk Life Science, INC. | $431.60 | 2021-2025 | Xcopri |
| Celgene Corporation | $418.74 | 2021-2025 | Zeposia |
| Novartis Pharmaceuticals Corporation | $388.05 | 2019-2021 | |
| Neurelis, INC. | $301.61 | 2021-2025 | Valtoco |
| Biogen, INC. | $296.69 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Pfizer INC. | $290.37 | 2020-2025 | |
| Abbvie INC. | $263.11 | 2022-2025 | Qulipta, Ubrelvy |
| Amgen INC. | $261.53 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $208.51 | 2022-2025 | Ingrezza, Ongentys |
| E.R. Squibb & Sons, L.L.C. | $196.48 | 2021-2022 | |
| Lilly USA, LLC | $177.35 | 2022-2025 | Kisunla, Amyvid, Emgality |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabor Zoltay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.